Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.
about
Preeclampsia and Extracellular VesiclesCardiovascular and inflammatory effects of intratracheally instilled ambient dust from Augsburg, Germany, in spontaneously hypertensive rats (SHRs)Traffic air pollution and oxidized LDLEndothelial Extracellular Vesicles-Promises and ChallengesBreast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cyclePlasminogen activator inhibitor type 1 gene polymorphism and sepsis.Early posttransplant changes in circulating endothelial microparticles in patients with kidney transplantation.Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescenceUrokinase and its receptors in chronic kidney disease.Bench-to-bedside review: circulating microparticles--a new player in sepsis?Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant stateBubble-Induced Endothelial Microparticles Promote Endothelial Dysfunction.Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions.Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.The lost correlation between heat shock protein 70 (HSPA1A) and plasminogen activator inhibitor-1 in patients with type 2 diabetes and albuminuria.Cyclosporine induces endothelial cell release of complement-activating microparticles.Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseasesCirculating microparticles: new insights into the biochemical basis of microparticle release and activity.The assessment of vascular function during dietary intervention trials in human subjects.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.Glucose and angiotensin II-derived endothelial extracellular vesicles regulate endothelial dysfunction via ERK1/2 activation.Communication Is Key: Mechanisms of Intercellular Signaling in Vasodilation.Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.Evaluating PAI-1 as a biomarker for stress in diving: human serum total PAI-1 is unaltered after 2 h dry exposures to 280 kPa hyperbaric air.Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients.Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats.Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study.Iberian Cured-Ham Consumption Improves Endothelial Function in Healthy Subjects.Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.
P2860
Q28079349-8B8E99F7-ACF9-4B67-8A45-9501E1A4CE44Q28383982-ACE1EAA4-EAF3-4BA1-930F-E5B40B1F521FQ28743422-EA784CDD-38CE-46F3-B04A-2C9B120A4829Q33639065-4F1BCBAC-A1B9-463C-B3E0-B5C7AC809D53Q33715393-5076C879-E3A3-4CAF-83AA-239701BD2C37Q33990846-0B8CEC2B-9FC5-4A51-9D5E-50075C75C936Q34076305-230A3DCA-E5C5-46C6-98F9-CE63C3F1BEA1Q34469009-0303B246-4340-45C5-990F-B5029381CB79Q35093088-4E8304BE-2B93-40E9-B339-124D253F05A8Q35124141-7410B463-D51D-4D83-A947-4503744BF79DQ35559151-93A5F776-5642-493E-8B61-4B2106974479Q36120543-C3233A2F-AE96-44CE-B9A7-DF246526F611Q36257626-EB458732-A367-44FF-8407-EFC2C2ABCCD3Q36452637-B6F08FBF-6214-412A-9E4D-C540D36B76D3Q36580760-811098F7-5690-4D81-9493-C1964E37B5EBQ36674119-B9CFE77A-DE0B-4FAE-8AB3-41B3DC5F895EQ37260192-95C14A4E-AD93-4A44-AFB5-EDA2A481A16BQ37316399-780C7205-4221-4AAE-AAD1-7694E4AB7D1CQ37892456-28187730-6DCA-47CC-A1BD-8F06CE4A6021Q37898220-8054743D-66F1-4046-B317-FA427E29126CQ38189275-34294407-2549-44B2-A7D7-4C9EE8AA340AQ38908954-20767778-E585-4031-BEF1-19525A6F1AF4Q39099983-D3930296-4753-416A-9928-63D6DE418D40Q39291123-96DD5231-5B65-406D-93C9-CED2E71F5309Q40112496-DC3CC272-CE33-49E9-A495-C0FA7C1A5652Q41760686-834F2E78-6E93-42F8-869B-8937CACE4172Q41966657-D6B2B075-4969-4988-ACBE-2655596CF06EQ42361529-893DF0C7-AB94-494F-B740-E8304EEABB61Q43108135-5D4B7346-C874-4FBB-86D4-D4EC7F20CCFDQ43214764-77D977A3-BEAD-4709-B109-1DDDA38F03BAQ46032945-95412ED7-90CC-4435-BD2E-F9D3242517B5Q46363692-33812FEF-71FB-4D6C-ACD2-037C8E304D17Q46718636-79955F49-2A99-4A2E-9057-30A842DAB095Q49498501-047AC118-1530-4AD1-B113-E9FC751F71A8Q54936719-3B8BE019-382D-4521-AAAF-BF81FE3D24A2
P2860
Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Plasminogen activator inhibito ...... s with procoagulant potential.
@ast
Plasminogen activator inhibito ...... s with procoagulant potential.
@en
type
label
Plasminogen activator inhibito ...... s with procoagulant potential.
@ast
Plasminogen activator inhibito ...... s with procoagulant potential.
@en
prefLabel
Plasminogen activator inhibito ...... s with procoagulant potential.
@ast
Plasminogen activator inhibito ...... s with procoagulant potential.
@en
P2093
P1433
P1476
Plasminogen activator inhibito ...... s with procoagulant potential.
@en
P2093
Jolyon Jesty
Kazimierz Malinowski
Marc Golightly
Michael S Goligorsky
Sergey V Brodsky
P304
P356
10.1161/01.CIR.0000033972.90653.AF
P407
P577
2002-10-01T00:00:00Z